MAPK8 and amyotrophic lateral sclerosis: Although it remains to be explored whether pharmacological activation of JNK1 is a plausible approach – especially in light of emerging small-molecule kinase activators28 – our findings demonstrate a proof-of-principle strategy for restoring astrocyte process structure and cargo distribution in ALS.